CRN addressed these concerns in a letter to FDA in December of 2020. Cara Welch, PhD, appearing director of the Office of Dietary Supplement Programs issued a short response to CRN in May, stating that FDA is “closely reviewing the knowledge provided in your letter and will provide a more substantive response once our evaluation
Read more
Recent Comments